Rebuilding synaptic architecture in HIV-1 associated neurocognitive disease: A therapeutic strategy based on modulation of mixed lineage kinase

Work from our laboratories has validated mixed lineage kinase type 3 (MLK3) as an enzyme pathologically activated in the CNS by human immunodeficiency virus 1 (HIV-1) neurotoxins. In this review, we discuss MLK3 activation in the context of the neuropathogenesis of HIV-1 associated neurocognitive de...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Gelbard, Harris A., Dewhurst, Stephen, Maggirwar, Sanjay B., Kiebala, Michelle, Polesskaya, Oksana, Gendelman, Howard E.
Format: Artigo
Langue:Inglês
Publié: Springer-Verlag 2010
Sujets:
Review Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2948545/
https://ncbi.nlm.nih.gov/pubmed/20880503
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nurt.2010.08.001
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires